Table 4.
Intervention | August 2020–March 2021 | June/July 2021 (Pilot Study) | LUMINNOVA Upper Respiratory Protocol |
---|---|---|---|
Oral MB | Optional: used if symptoms were severe/delayed presentation | Initially 1 mg/kg administered 12-hourly. |
Up to 2 mg/kg administered 8-hourly for a total of 8 treatments (unless contraindicated or very mild presentation). |
Sublingual PBM | Not utilized | Initially utilized for a patient that had not adequately responded to oral MB and in a case where oral MB was contraindicated. | Administered eight treatments every 8 h or until symptoms were resolved |
Oral/nasal PDT | Total of two treatment sessions 12 h apart. | The number of treatment sessions gradually evolved as we observed the changes in CT values each day. | Treatment course consisted of eight sessions carried out every 8 h. |